This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Aug;46(8):1156-7.

doi: 10.1038/bmt.2010.251. Epub 2010 Oct 25.

High-dose chemotherapy with autologous stem cell rescue for relapse after allo-SCT in multiple myeloma

H H Tuncer, S A Gregory, H C Fung

PMID: 20972468
DOI: 10.1038/bmt.2010.251

Comment

High-dose chemotherapy with autologous stem cell rescue for relapse after allo-SCT in multiple myeloma

H H Tuncer et al. Bone Marrow Transplant. 2011 Aug.

. 2011 Aug;46(8):1156-7.

doi: 10.1038/bmt.2010.251. Epub 2010 Oct 25.

Authors

H H Tuncer, S A Gregory, H C Fung

PMID: 20972468
DOI: 10.1038/bmt.2010.251

No abstract available

PubMed Disclaimer

Comment on

Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma.
Gerull S, Goerner M, Benner A, Hegenbart U, Klein U, Schaefer H, Goldschmidt H, Ho AD. Gerull S, et al. Bone Marrow Transplant. 2005 Dec;36(11):963-9. doi: 10.1038/sj.bmt.1705161. Bone Marrow Transplant. 2005. PMID: 16184182
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma.
van de Donk NW, Kröger N, Hegenbart U, Corradini P, San Miguel JF, Goldschmidt H, Perez-Simon JA, Zijlmans M, Raymakers RA, Montefusco V, Ayuk FA, van Oers MH, Nagler A, Verdonck LF, Lokhorst HM. van de Donk NW, et al. Bone Marrow Transplant. 2006 Jun;37(12):1135-41. doi: 10.1038/sj.bmt.1705393. Bone Marrow Transplant. 2006. PMID: 16757975

Similar articles

Treatment of multiple myeloma.
San Miguel JF, Bladé Creixenti J, García-Sanz R. San Miguel JF, et al. Haematologica. 1999 Jan;84(1):36-58. Haematologica. 1999. PMID: 10091392 Review.
Strategies to improve the outcome of stem cell transplantation in multiple myeloma.
Catley L, Anderson K. Catley L, et al. Hematol J. 2004;5(1):9-23. doi: 10.1038/sj.thj.6200322. Hematol J. 2004. PMID: 14745425 Review.
Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.
Björkstrand B, Iacobelli S, Hegenbart U, Gruber A, Greinix H, Volin L, Narni F, Musto P, Beksac M, Bosi A, Milone G, Corradini P, Goldschmidt H, de Witte T, Morris C, Niederwieser D, Gahrton G. Björkstrand B, et al. J Clin Oncol. 2011 Aug 1;29(22):3016-22. doi: 10.1200/JCO.2010.32.7312. Epub 2011 Jul 5. J Clin Oncol. 2011. PMID: 21730266
Is there still a role for stem cell transplantation in multiple myeloma?
Mina R, Lonial S. Mina R, et al. Cancer. 2019 Aug 1;125(15):2534-2543. doi: 10.1002/cncr.32060. Epub 2019 Apr 15. Cancer. 2019. PMID: 30985927 Review.
Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.
El-Cheikh J, Crocchiolo R, Furst S, Stoppa AM, Ladaique P, Faucher C, Calmels B, Lemarie C, De Colella JM, Granata A, Coso D, Bouabdallah R, Chabannon C, Blaise D. El-Cheikh J, et al. Am J Hematol. 2013 May;88(5):370-4. doi: 10.1002/ajh.23412. Epub 2013 Mar 5. Am J Hematol. 2013. PMID: 23460414

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information